Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older who have been diagnosed with either pancreatic ductal adenocarcinoma (a type of pancreatic cancer) or a pancreatic neuroendocrine tumor (another type of pancreatic tumor)
- People whose doctors estimate they have a life expectancy of 4 months or more
- People who get more than 60% of their daily calories through eating by mouth or through a feeding tube that goes into the digestive system
- People diagnosed with a pancreatic neuroendocrine tumor who also have signs of digestive system problems, such as losing more than 5% of body weight without trying, more frequent bowel movements, or changes in stool consistency like loose stools or diarrhea — and where these signs have been recorded in their medical records and confirmed by their cancer doctor
Who may not be able to join:
- People who are pregnant or currently breastfeeding
- People who are completely unable to eat or drink anything by mouth
- People who have an allergy to soy lecithin or its ingredients
- People whose personal or social circumstances might make taking part in the study difficult for them or their family, as assessed by the medical team
- People currently serving in or employed by the U.S. military, Reserve or National Guard, or working as Department of Defense civilians or contractors
- People who do not have the capacity to give their own informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Virginia A Stallings, MD, Children's Hospital of Philadelphia
Phone: 267-426-9381
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of Encala Intervention ( Enrollment Rate ); Change in PROMIS Gastrointestinal Symptom Score; Feasibility of Encala Intervention ( Retention Rate ); Feasibility of Encala Intervention ( Visit Completion); Feasibility of Encala Intervention ( Product Adherence )
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.